Drug recall
Doxepin Hydrochloride Oral Solution, USP (Concentrate), 10 mg/ml, 120 mL (4 fl.oz.) bottle, Rx only, Teva…
FDA recall event 30367 · Class III · Teva Pharmaceuticals USA
Key facts
| Event ID | 30367 |
|---|---|
| Recall numbers | D-075-5 |
| Recalling firm | Teva Pharmaceuticals USA |
| Product type | Drugs |
| Products | Doxepin Hydrochloride Oral Solution, USP (Concentrate), 10 mg/ml, 120 mL (4 fl.oz.) bottle, Rx only, Teva Pharmaceuticals, Sellersville, PA 18960 ***** NDC 0093-9612-12 |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Failed pH specification (6 month stability) |
| Initiation date | Nov 3, 2004 |
| City | North Wales |
| Country | United States |
| FEI number | 3003092769 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports